Key result
Maternal history of preterm delivery shows no link to clinical restenosis after PCI in women.
Why the study?
Women's pregnancy history is associated with incident CAD risk and may have prognostic relevance following treatment, but its relationship with post-PCI restenosis was unclear.
Does a maternal history of adverse pregnancy outcomes increase the risk of clinical restenosis or target lesion revascularisation after PCI in women?
Cohort
Yes
Does a maternal history of adverse pregnancy outcomes increase the risk of clinical restenosis or target lesion revascularisation after PCI in women?
Answers are grounded in this paper and cite their sources.
Maternal history of adverse pregnancy outcomes, including preterm delivery, is not significantly associated with an increased risk of clinical restenosis or TLR after PCI in young and middle-aged women.
BACKGROUND: Women's pregnancy history is associated with incident risk of coronary artery disease with some evidence also suggesting a relevance for prognosis following treatment. OBJECTIVES: To study the associations between maternal history of preterm delivery, a history of small for gestational age infant, parity and age at first delivery with clinical restenosis after percutaneous coronary intervention (PCI). METHODS: 65 years undergoing their first PCI 2006-2017, merging clinical register data on PCI procedures in Sweden with comprehensive registry data on deliveries since 1973. We used proportional hazards regression to study the association between aspects of pregnancy history and clinical restenosis in per-segment analyses, and with target lesion revascularisation (TLR) in per-patient analyses. We adjusted models for procedural-related and patient-related predictors of restenosis. RESULTS: During 15 981 segment-years of follow-up, 343 (3.7%) events of clinical restenosis occurred. We found no strong evidence of associations between the studied aspects of pregnancy history and clinical restenosis following PCI. For example, the restenosis HR for a history of preterm delivery in the fully adjusted model was 1.09 (95% CI 0.77 to 1.55) and the TLR HR was 1.18 (95% CI 0.91 to 1.52). CONCLUSION: Risk of restenosis following treatment with PCI did not differ by the studied aspects of pregnancy history, including preterm delivery, in young and middle-aged women. Larger studies are needed to obtain more precise estimates.
No takes yet. Share an insight, caveat, or question.
Pehrson et al. (2023) conducted a cohort in Coronary artery disease requiring percutaneous coronary intervention. Maternal history of preterm delivery vs. No history of preterm delivery was evaluated on Clinical restenosis (HR 1.09, 95% CI 0.77-1.55). A maternal history of preterm delivery was not significantly associated with clinical restenosis (HR 1.09; 95% CI 0.77-1.55) or target lesion revascularisation following PCI in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: